Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001176256-10-000285
Filing Date
2010-03-31
Accepted
2010-03-31 17:14:24
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 dragon10k091231.htm 10-K 615031
2 CONSENT OF CHANG LEE LLP exhibit23-1.htm EX-23.1 1419
3 CONSENT OF ERNST & YOUNG LLP exhibit23-2.htm EX-23.2 2117
4 SOX SECTION 302 CEO CERTIFICATION exhibit31-1.htm EX-31.1 8559
5 SOX SECTION 302 CFO CERTIFICATION exhibit31-2.htm EX-31.2 8224
6 SOX SECTION 906 CEO AND CFO CERTIFICATIONS exhibit32.htm EX-32 4998
  Complete submission text file 0001176256-10-000285.txt   641980
Mailing Address 650 WEST GEORGIA STREET, SUITE 310 VANCOUVER BRITISH COLUMBIA CANADA V6C1X VANCOUVER BRITISH CO A1 V6B 4N9
Business Address 650 WEST GEORGIA STREET, SUITE 310 VANCOUVER BC V6B 4N9 A1 V6E 2E9 6046698817
DRAGON PHARMACEUTICAL INC (Filer) CIK: 0001075206 (see all company filings)

EIN.: 650142474 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27937 | Film No.: 10720339
SIC: 2834 Pharmaceutical Preparations